Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 103 | 114 | 75 | 59 | 74 |
| Cost of Goods | 33 | 37 | 42 | 31 | 31 |
| Gross Profit | 69 | 77 | 32 | 28 | 43 |
| Operating Expenses | 804 | 959 | 509 | 625 | 939 |
| Operating Income | -735 | -882 | -476 | -598 | -896 |
| Interest Expense | 59 | 28 | 24 | 24 | 24 |
| Other Income | 3 | 672 | 1 | 5 | 68 |
| Pre-tax Income | -791 | -238 | -500 | -616 | -851 |
| Net Income Continuous | -791 | -238 | -500 | -616 | -851 |
| Net Income | $-791 | $-238 | $-500 | $-616 | $-851 |
| EPS Basic Total Ops | -0.02 | -0.01 | 0.00 | -0.02 | -0.05 |
| EPS Basic Continuous Ops | -0.02 | -0.01 | 0.00 | -0.02 | -0.05 |
| EPS Diluted Total Ops | -0.02 | -0.01 | 0.00 | -0.02 | -0.05 |
| EPS Diluted Continuous Ops | -0.02 | -0.01 | 0.00 | -0.02 | -0.05 |
| EBITDA(a) | $-719 | $-197 | $-464 | $-579 | $-815 |